Related Experiment Video
Updated: Sep 3, 2025

09:35
A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research
Published on: August 16, 2017
17.9K
Genetic Background Matters: Population-Based Studies in Model Organisms for Translational Research.
Valeria Olguín1, Anyelo Durán1, Macarena Las Heras1
1Centro de Genética y Genómica, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago 7610658, Chile.
International Journal of Molecular Sciences
|July 27, 2022
Summary
Genetic variations cause differences in patient symptoms and treatment responses. Using diverse animal models, like mouse, fly, and yeast panels, improves the reproducibility of therapies for human translational research.
Area of Science:
- Genetics
- Translational Research
- Animal Models
Background:
- Human patients exhibit significant heterogeneity in symptoms and treatment responses, often linked to genomic variations.
- Traditional animal studies using single strains lack this variability, hindering the translation of findings to human clinical applications.
- Reproducibility of therapeutic interventions is a major challenge in biomedical research.
Purpose of the Study:
- To review the current knowledge and applications of genetically diverse animal panels (mouse, fly, yeast) in translational research.
- To highlight the utility of these panels in modeling human phenotypic heterogeneity.
- To discuss their role in advancing gene mapping and therapeutic development.
Main Methods:
- Review of existing literature on genetically diverse panels of model organisms.
- Analysis of studies utilizing mouse, fruit fly (Drosophila melanogaster), and yeast (Saccharomyces cerevisiae) panels.
- Examination of applications in disease modeling and drug discovery.
Main Results:
- Genetically diverse panels effectively mimic human phenotypic variability, offering a more realistic preclinical testing ground.
- These panels facilitate gene mapping by allowing researchers to study the effects of genetic variations on phenotypes.
- Studies using these panels show improved potential for identifying robust and translatable therapeutic targets.
Conclusions:
- Genetically diverse panels of model organisms are essential tools for understanding human disease heterogeneity.
- Their application enhances the reproducibility and translational success of preclinical research.
- Further development and utilization of these panels will accelerate the discovery of effective human therapies.

